Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor ConferenceGlobeNewsWire • 03/28/24
Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual MeetingGlobeNewsWire • 03/25/24
Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor ConferenceGlobeNewsWire • 02/21/24
Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual ConferenceGlobeNewsWire • 02/14/24
Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price RuleGlobeNewsWire • 02/06/24
Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 DosesGlobeNewsWire • 01/25/24
Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast CancerGlobeNewsWire • 01/19/24
Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over CapecitabineGlobeNewsWire • 12/19/23
Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation CapecitabineGlobeNewsWire • 12/13/23
Processa Pharmaceuticals to Present at the MedInvest Oncology Investor ConferenceGlobeNewsWire • 11/30/23
Processa Pharmaceuticals Issues Letter to Shareholders Highlighting Corporate Strategy, Drug Pipeline, and OutlookGlobeNewsWire • 11/29/23
Processa Pharmaceuticals, Inc. Mourns the Sudden Passing of Board Member Virgil ThompsonGlobeNewsWire • 11/13/23
Processa Pharmaceuticals to Present at the 20th Orphan Drugs and Rare Diseases Global Congress 2023 AmericasGlobeNewsWire • 11/09/23
Processa Pharmaceuticals Announces Formation of Oncology Advisory Board with Renowned Key Opinion LeadersGlobeNewsWire • 11/01/23
Processa Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceGlobeNewsWire • 09/06/23
Processa Pharmaceuticals Provides Data Update Supporting a Potential Personalized Treatment Approach for Improved Cancer CareGlobeNewsWire • 08/17/23
Processa Pharmaceuticals to Present at the Sidoti & Co. Micro Cap Virtual ConferenceGlobeNewsWire • 08/10/23